Answers are grounded in this paper and cite their sources.
Background: Healthcare total spending accelerated during the COVID-19 pandemic. Understanding broad high- and low-cost healthcare utilization while the healthcare system is under stress can help identify strategies and gaps to improve the future quality of care while reducing high-cost care and maximizing low-cost care. Methods: This was a population-based cross-sectional study with 56,141 individuals in the U.S. using 2020–2021 Medical Expenditure Panel Survey (MEPS) data sources. We applied a Poisson regression approach to test differences among patients with/without cancer/COVID-19 in healthcare utilization outcomes, including emergency department (ED) visits, inpatient discharge, inpatient nights of stay, outpatient visits, and home provider days. Results: Outpatient visits were affected by both cancer and COVID-19 diagnoses (86% to 109% higher for individuals with cancer and/or COVID-19, p < 0.001). COVID-19 patients with/without cancer had statistically significant increases in high-cost care, including (1) ED visits (151% to 245% higher, p < 0.001), (2) number of inpatient visits (94% to 170%, p < 0.001, p < 0.001), and (3) inpatient nights of stay (259% to 268% higher, p < 0.001). There were no statistically significant differences in home-based utilization when compared to individuals without cancer and without COVID-19. Conclusions: Improving and adopting innovative low-cost home-based care utilization are critical to reduce future healthcare spending and strengthen pandemic preparedness.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: